Ocular involvement in hemolytic uremic syndrome due to factor H deficiency—are there therapeutic consequences?
- 10 July 2007
- journal article
- case report
- Published by Springer Nature in Pediatric Nephrology
- Vol. 22 (11), 1967-1970
- https://doi.org/10.1007/s00467-007-0540-0
Abstract
Factor H deficiency is responsible for thrombotic microangiopathy (TMA) via uncontrolled activation of the alternative pathway of the complement system. Ocular TMA has never been reported in patients with factor H abnormalities. A male patient with congenital homozygote factor H deficiency reached end-stage renal disease at the age of 10 years. Hemodialysis was uneventful for 3 years, when, suddenly, unilateral ocular pain and blurred vision occurred while he had febrile pharyngitis. Ophthalmologic examination found vitreous bleeding, elevated ocular pressure, choroidal hemorrhage (ultrasound biomicroscopy) and retinal ischemia (fluorescein angiography). C-reactive protein concentration was increased, while haptoglobin levels remained normal. We suspected that TMA due to factor H deficiency was responsible for the ocular manifestations and immediately initiated daily plasma exchanges (PEs) with fresh frozen plasma (FFP) for 10 days followed by three sessions per week. Factor H serum level increased from 6% to 82%, and C3 level normalized. Progressively, ocular pain decreased, and visual acuity and ophthalmologic findings showed improvement. When there is permanent activation of the alternative pathway in patients with end-stage renal disease (ESRD), the search for secondary targets might be of interest. In nephrectomized patients, no biological parameter can predict isolated ocular TMA. Early ophthalmologic investigation and substitution of factor H via FFP may avoid irreversible damage.Keywords
This publication has 19 references indexed in Scilit:
- Secondary failure of plasma therapy in factor H deficiencyPediatric Nephrology, 2006
- Favorable Long-Term Outcome after Liver-Kidney Transplant for Recurrent Hemolytic Uremic Syndrome Associated with a Factor H MutationAmerican Journal of Transplantation, 2006
- Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)Kidney International, 2006
- The molecular biology of thrombotic microangiopathyKidney International, 2006
- Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic SyndromeJournal of the American Society of Nephrology, 2005
- Retinal changes associated with type 2 glomerulonephritisEye, 2004
- Augenveränderungen bei thrombotisch-thrombozytopenischer Purpura (Moschcowitz-Syndrom)Klinische Monatsblätter für Augenheilkunde, 2002
- Cobalamin C Disease Presenting as Hemolytic-Uremic Syndrome in the Neonatal PeriodJournal of Pediatric Hematology/Oncology, 2002
- Ocular involvement in hemolytic-uremic syndromeThe Journal of Pediatrics, 1988
- Central Retinal Vein Occlusion Associated with HemodialysisThe American Journal of the Medical Sciences, 1979